AHAlfred P. Hallstrom

Alfred P. Hallstrom

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alfred P. Hallstrom has a total of 52 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A modified Wilcoxon test for non‐negative distributions with a clump of zeros

    by Alfred P. Hallstrom

    Comparing two samples with a continuous non‐negative score, e.g. a utility score over [0, 1], with a substantial proportion, say 50 per cent, scoring 0 presents distributional problems for most standard tests. A Wilcoxon rank test can be used, but the large number of ties reduces power. I propose a new test, the Wilcoxon rank‐sum test performed after removing an equal (and maximal) number of 0's from each sample. This test recovers much of the power. Compared with a (directional) modification of a two‐part test proposed by Lachenbruch, the truncated Wilcoxon has similar power when the non‐zero scores are independent of the proportion of zeros, but, unlike the two‐part test, the truncated Wilcoxon is relatively unaffected when these processes are dependent. Copyright © 2009 John Wiley & Sons, Ltd.


  • Treatment of asystole and PEA

    by A. Hallstrom, J. Herlitz, K. Kajino, T.M. Olasveengen


  • Clinical criteria for predicting benefit of ICD/PM in post myocardial infarction patients: an AVID and CAST analysis

    by Alfred P. Hallstrom, D. George Wyse, John McAnulty, for the CAST and AVID Investigators

    Three clinical factors from the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial—heart failure, left ventricular dysfunction and certain historical features defined a subgroup in which an implantable cardioverter defibrillator (ICD/PM) has a mortality advantage over amiodarone.


  • Open Access

    Pearls and perils of an implantable defibrillator trial using a common control: implications for the design of future studies

    by Peter J Kudenchuk, Alfred P Hallstrom

    Implantable defibrillators are considered life-saving therapy in heart failure (CHF) patients. Surprisingly, the recent Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) reached an opposing conclusion from that of numerous other trials about their survival benefit in patients with advanced CHF. A critical analysis of common control trial design may explain this paradoxical finding, with important implications for future studies. Common control trials compare several intervention groups to a single rather than separate control groups. Though potentially requiring fewer patients than trials using separate controls, variation in the common control group will influence all comparisons and creates correlations between findings. During subgroup analyses, this dependency of outcomes may increase belief in the presence of a real subgroup effect when, in fact, it should increase skepticism. For example, a high (r = 0.92), statistically unlikely (p = 0.052) correlation between comparisons was observed across the subgroups reported in SCD-HeFT. Such concordance between amiodarone and a defibrillator across subgroups was unexpected, given how much the effects of these treatments significantly differed from one another in the main study. This suggests the study's subgroup findings (specifically the absence of benefit from defibrillators in advanced CHF) were not necessarily a consequence of treatment; more likely, they resulted from variation in what the treatments were compared against, the common control. Common control trials can be more efficient than other designs, but induce dependence between treatment comparisons and require cautious interpretation.


  • The relationship between shocks and survival in out-of-hospital cardiac arrest patients initially found in PEA or asystole

    by Al Hallstrom, Thomas D. Rea, Vince N. Mosesso, Leonard A. Cobb, Andy R. Anton, Lois Van Ottingham, Michael R. Sayre, James Christenson


  • Manual Chest Compression vs Use of an Automated Chest Compression Device During Resuscitation Following Out-of-Hospital Cardiac Arrest

    by Al Hallstrom, Thomas D. Rea, Michael R. Sayre, James Christenson, Andy R. Anton, Vince N. Mosesso, Lois Van Ottingham, Michele Olsufka, Sarah Pennington, Lynn J. White, et al.

    Research from JAMA — Manual Chest Compression vs Use of an Automated Chest Compression Device During Resuscitation Following Out-of-Hospital Cardiac Arrest — A Randomized Trial — ContextHigh-quality cardiopulmonary resuscitation (CPR) may improve both cardiac and brain resuscitation following cardiac arrest. Compared with manual chest compression, an automated load-distributing band (LDB) chest compression device produces greater blood flow to vital organs and may improve resuscitation outcomes.ObjectiveTo compare resuscitation outcomes following out-of-hospital cardiac arrest when an automated LDB-CPR device was added to standard emergency medical services (EMS) care with manual CPR.Design, Setting, and PatientsMulticenter, randomized trial of patients experiencing out-of-hospital cardiac arrest in the United States and Canada. The a priori primary population was patients with cardiac arrest that was presumed to be of cardiac origin and that had occurred prior to the arrival of EMS personnel. Initial study enrollment varied by site, ranging from late July to mid November 2004; all sites halted study enrollment on March 31, 2005.InterventionStandard EMS care for cardiac arrest with an LDB-CPR device (n = 554) or manual CPR (n = 517).Main Outcome MeasuresThe primary end point was survival to 4 hours after the 911 call. Secondary end points were survival to hospital discharge and neurological status among survivors.ResultsFollowing the first planned interim monitoring conducted by an independent data and safety monitoring board, study enrollment was terminated. No difference existed in the primary end point of survival to 4 hours between the manual CPR group and the LDB-CPR group overall (N = 1071; 29.5% vs 28.5%; P = .74) or among the primary study population (n = 767; 24.7% vs 26.4%, respectively; P = .62). However, among the primary population, survival to hospital discharge was 9.9% in the manual CPR group and 5.8% in the LDB-CPR group (P = .06, adjusted for covariates and clustering). A cerebral performance category of 1 or 2 at hospital discharge was recorded in 7.5% of patients in the manual CPR group and in 3.1% of the LDB-CPR group (P = .006).ConclusionsUse of an automated LDB-CPR device as implemented in this study was associated with worse neurological outcomes and a trend toward worse survival than manual CPR. Device design or implementation strategies require further evaluation.Trial Registrationclinicaltrials.gov Identifier: NCT00120965


  • Characteristics of heart beat intervals and prediction of death

    by Alfred P. Hallstrom, Phyllis K. Stein, Raphael Schneider, Morrison Hodges, Georg Schmidt, Kurt Ulm


  • Structural Relationships Between Measures Based on Heart Beat Intervals: Potential for Improved Risk Assessment

    by A.P. Hallstrom, P.K. Stein, R. Schneider, M. Hodges, G. Schmidt, K. Ulm

    Decreased left ventricular ejection fraction is the most commonly used risk factor for identification of patients at high-risk for lethal ventricular arrhythmic events. Twenty-four-hour electrocardiographic (ECG) approaches to risk stratification include: counts of ventricular premature contractions (VPCs), measures of heart rate variability (HRV), and heart rate turbulence (HRT) which has two components, turbulence onset and turbulence slope (TS). Refinement of these ECG risk stratifiers could enhance their clinical utility. We explored the structural relationships between heart rate (HR) and HRV and HRT measures. Our goal was to separate out the component of these measures due to the underlying average heart rate (HR), thus potentially reducing the variability of the measures and increasing their power to stratify risk. We proposed re-scaling tachograms of heart-beat intervals so that the re-scaled tachogram has a HR of 75 (or equivalently an average interval of 800 ms) and calculating HRV and HRT from the rescaled time series. We also explored the relationship between the number of VPCs and HRT. We showed that TS is structurally related to the number of VPCs (and hence to the length of the ECG recording). We proposed an adjusted TS that is independent of the number of VPCs. We also addressed the ability of shorter ECG recording to estimate HRV and HRT measures. We evaluated standard and rescaled HRV and HRT measures using qualifying ambulatory ECG recordings from 744 patients in the Cardiac Arrhythmia Suppression Trial. We found that measures based on the rescaled tachogram had reduced variance (20% to 40%). Correlations between measures were also substantially reduced. We also found substantial circadian effects on some, but not all HRV indices, not explained by the circadian pattern in HR and possibly pointing to additional measures for risk prediction. In conclusion, we found that adjusting for HR and the number of VPCs in heart-beat related ambulatory ECG measures has the potential to significantly improve the power of these measures to risk stratify cardiac patients.